![Carole Monterrat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Carole Monterrat
Anciens postes connus de Carole Monterrat
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sopartec SA
![]() Sopartec SA Investment ManagersFinance Sopartec SA is the investment and technology valorization arm of Université Catholique de Louvain (UCL) and was founded in 1942. Sopartec SA is headquartered in Louvain-la-Neuve, Belgium. | Directeur Financier/CFO | 01/03/2014 | 01/09/2018 |
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Corporate Officer/Principal | 03/11/2009 | 01/03/2014 |
Formation de Carole Monterrat
Université de Bordeaux | Doctorate Degree |
Université Catholique de Louvain | Masters Business Admin |
Statistiques
Internationale
Belgique | 4 |
France | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
Sopartec SA
![]() Sopartec SA Investment ManagersFinance Sopartec SA is the investment and technology valorization arm of Université Catholique de Louvain (UCL) and was founded in 1942. Sopartec SA is headquartered in Louvain-la-Neuve, Belgium. | Finance |
- Bourse
- Insiders
- Carole Monterrat
- Expérience